Evaluation of long-term infusion of dexmedetomidine in critically ill patients: A retrospective analysis

BACKGROUND: Dexmedetomidine is an α2-receptor agonist used for sedation in the intensive care unit (ICU). It is currently FDA indicated for short-term use (i.e., less than 24 h). OBJECTIVES: To compare the safety and efficacy of dexmedetomidine if given long- term (>24 h) to short-term infusion (...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuhasna, Said, Al Jundi, Amer, Abdelatty, Wael, urRahman, Masood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401820/
https://www.ncbi.nlm.nih.gov/pubmed/22837894
http://dx.doi.org/10.4103/2229-5151.97270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401820/
https://www.ncbi.nlm.nih.gov/pubmed/22837894
http://dx.doi.org/10.4103/2229-5151.97270

Ejemplares similares